TBPH PEER ANALYSIS

Theravance Biopharma Inc — metric-by-metric comparison with peers and the industry median

TBPHTheravance Biopharma Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

TBPHIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	TBPH	MSB	TLX	RTALB	CSL	Ind. Median
P/E	7.61	—	—	4.89●	30.02	17.81
P/B	3.00	—	6.56	0.61●	2.24	3.49
EV/EBITDA	3.86●	—	123.31	74.61	10.37	14.92
P/S	7.94	31.91	3.34	6.67	2.67●	10.89

Financial Health
Metric	TBPH	MSB	TLX	RTALB	CSL	Ind. Median
Current Ratio	13.14●	—	1.43	1.21	2.57	5.90
Debt/Equity	25.2%	—	112.3%	1.2%●	67.4%	10.9%
NetDebt/EBITDA	-2.26●	—	13.13	0.90	2.22	1.15

Profitability
Metric	TBPH	MSB	TLX	RTALB	CSL	Ind. Median
Net Margin	104.3%	-115.3%	-0.9%	136.3%●	9.2%	-125.7%
ROE	50.2%●	-11.3%	-1.8%	15.1%	7.7%	-47.5%
ROA	28.1%●	-8.6%	-0.7%	13.1%	3.8%	-35.8%
EBITDA Margin	129.8%●	-76.6%	3.0%	9.0%	32.8%	-105.8%

Growth + Dividend
Metric	TBPH	MSB	TLX	RTALB	CSL	Ind. Median
Rev. Growth	68.2%	410.4%●	56.3%	24.0%	4.8%	5.1%
NI Growth	—	—	—	134.0%●	-39.4%	12.1%
Div. Yield	—	0.0%	—	0.0%	2.5%●	0.2%
Payout	—	0.0%	—	0.0%	103.1%	0.0%

Valuation
Metric	TBPH	MRVI	FDMT	SPRY	ZVRA	GERN	Ind. Median
P/E	7.61	—	—	—	—	—	17.81
P/B	3.00	4.08	1.92●	13.49	4.09	4.21	3.49
EV/EBITDA	3.86	—	—	—	—	—	14.92
P/S	7.94	4.22●	9.81	8.36	—	4.91	10.89

Financial Health
Metric	TBPH	MRVI	FDMT	SPRY	ZVRA	GERN	Ind. Median
Current Ratio	13.14●	5.91	9.34	4.94	4.89	6.78	5.90
Debt/Equity	25.2%	128.0%	4.5%	157.4%	0.6%●	109.9%	10.9%
NetDebt/EBITDA	-2.26●	-1.01	2.27	0.54	—	1.69	1.15

Profitability
Metric	TBPH	MRVI	FDMT	SPRY	ZVRA	GERN	Ind. Median
Net Margin	104.3%●	-51.1%	-182.3%	-200.0%	—	-35.5%	-125.7%
ROE	50.2%●	-40.8%	-34.9%	-136.4%	—	-28.0%	-47.5%
ROA	28.1%●	-12.5%	-31.3%	-64.4%	—	-12.7%	-35.8%
EBITDA Margin	129.8%●	-50.8%	-185.2%	-194.1%	—	-18.8%	-105.8%

Growth + Dividend
Metric	TBPH	MRVI	FDMT	SPRY	ZVRA	GERN	Ind. Median
Rev. Growth	68.2%	-15.4%	383,560.9%●	1.9%	—	68.6%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on TBPH

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.